Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focusing on developing innovative products for treating serious illnesses. They are working on various drugs targeting cancer cells, obesity, and solid tumors, with ongoing clinical trials and licensing agreements.